Skip to main content
. 2013 Feb 18;8(2):e56865. doi: 10.1371/journal.pone.0056865

Figure 5. Correlation studies between cell survival, MCL1 and BCL2A1 expression in IL-17A-treated DC.

Figure 5

DC were cultured 7 days with IL-17A (eight doses from 0.016 to 2 ng/ml). Flow cytometry analysis of (A) survival, assessed by DiOC6 and PI staining, (B) BCL2A1 and (C) MCL1 intracellular expressions for three donors (5, 8, 9), in separated experiments, SD<2%.